Form 4: Sonoma Pharmaceuticals Controller Acquires 15,000 Shares as Part of Annual Bonus

John Dal Poggetto, Controller of Sonoma Pharmaceuticals, acquired 15,000 shares of common stock as part of his annual bonus compensation.

Summary

• On June 20, 2024, John Dal Poggetto, Controller of Sonoma Pharmaceuticals, acquired 15,000 shares of common stock.
• The acquisition was part of the company's annual bonus compensation for executives.
• The shares were awarded as Restricted Stock Units and vested in full on the grant date.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to executive compensation. It doesn't contain information that would significantly sway investor sentiment positively or negatively.

Positives

• The award of shares as part of the annual bonus compensation could be seen as a positive sign of the company's commitment to its executives.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates an executive receiving stock as part of their compensation, which is a common practice.

Stakeholder Impact

• The acquisition of shares by a company executive may have a minor positive impact on shareholder confidence.

Key Dates

Keywords

Sonoma Pharmaceuticals, SNOA, John Dal Poggetto, Controller, Stock Acquisition, Restricted Stock Units, Annual Bonus, Executive Compensation, Form 4